Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bilal F. Hamzeh has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Comparison of Perioperative and Postoperative Outcomes Following Orthognathic Surgery in Patients With and Without Cleft Lip and/or Palate

    by Thalia Le, Celia Ernstrom, Bilal Hamzeh, Kenneth Huynh, Lauren Kiel, Donald Hull, Brooke French, David Khechoyan, Phuong D. Nguyen, Jason W. Yu

    Background: Orthognathic surgery in patients with cleft lip and/or palate (CLP) presents unique anatomical and surgical challenges. This study compared postoperative complications between cleft and noncleft patients undergoing orthognathic surgery. Material and Methods: A retrospective study at a single tertiary craniofacial center compared patient characteristics and perioperative outcomes between cleft and noncleft patients undergoing orthognathic surgery. Results: A total of 118 procedures in 115 patients (69 CLP, 49 noncleft) were included. Median follow-up was 225.5 days (interquartile range [IQR], 51–702) in the cleft cohort and 100 days (IQR, 1–375) in the noncleft cohort. Cleft lip and/or palate patients more frequently presented with Angle Class III malocclusion (81.2% versus 55.1%, P =0.002), crossbite (43.5% versus 20.4%, P =0.009), and deviated nasal septum (47.8% versus 20.4%, P =0.002), while noncleft patients more commonly presented with mandibular hypoplasia (32.7% versus 14.5%, P =0.019) and Angle Class II malocclusion (26.5% versus 8.7%, P =0.009). Hemifacial/craniofacial microsomia was also more common in the noncleft cohort (12.2% versus 1.4%, P =0.020). Bone graft utilization trended higher in the CLP cohort (56.5% versus 38.8%, P =0.057). Operative time, blood loss, and length of stay were comparable between groups. Skeletal/dental relapse occurred more frequently in the CLP cohort (14.5% versus 0.0%, P =0.005), while overall complications trended higher without reaching significance (33.3% versus 22.4%, P =0.198). On multivariable analysis, cleft status was not independently associated with adverse outcomes. Instead, syndromic status was the most consistent independent predictor of readmission (Firth-penalized OR 6.56, P =0.011), relapse (Firth-penalized OR 8.41, P = 0.004), and overall complications (MLE OR 3.33, P = 0.038; Firth-penalized OR 3.09, P = 0.050). Elevated ASA class (>2) was associated with overall complications on univariable analysis but did not remain independently predictive after adjustment (OR 1.84, P =0.314). Conclusions: Within this single-center cohort, syndromic diagnosis and medical complexity, rather than cleft status alone, were the principal correlates of adverse outcomes. These exploratory findings support risk stratification that prioritizes syndromic and systemic factors in orthognathic surgery.

  • Open Access

    Effects of GLP-1 Receptor Agonists on Breast Reconstruction Outcomes: A Large-Database Retrospective Study

    by Bilal F. Hamzeh, Christopher R. Orear, Markos Mardourian, Carson Keeter, Katie G. Egan, Julian Winocour, George Kokosis, David W. Mathes, Christodoulos Kaoutzanis

    Background/Objectives: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are increasingly prescribed for diabetes and weight loss, with many breast reconstruction candidates being prescribed these medications. However, perioperative risks remain unclear. This study evaluated the association between GLP-1RA use and postoperative complications in implant-based and autologous tissue breast reconstruction. Methods: A retrospective analysis of TriNetX identified patients undergoing implant-based or autologous tissue breast reconstruction. Preoperative GLP-1RA users were compared to matched controls. Patients were propensity score matched (1:1 and 1:3) for demographics and comorbidities including body-mass index and timing of reconstruction (delayed vs. immediate). Ninety-day outcomes were assessed using logistic regression. Results: Between 2014 and 2024, 57,987 patients were identified, of which 823 were GLP-1RA users. Of those users, 326 patients undergoing implant-based reconstruction and 51 patients undergoing autologous reconstruction were matched to controls. In implant-based cohorts, GLP-1RA use was associated with increased odds of implant failure (1:1 OR 1.70, 95% CI 1.18–2.45, p = 0.0046), wound healing complications (1:1 OR 1.90, p = 0.027), and higher readmission/ED utilization (1:1 OR 1.80, 95% CI 1.04–3.21, p = 0.040). No significant differences were observed for hematoma, seroma, or thromboembolism. In autologous reconstruction, GLP-1RA use was not associated with increased risks. Conclusions: GLP-1RA use is linked to higher rates of implant failure, wound healing complications, and readmission in implant-based breast reconstruction only. These findings highlight the need for risk stratification and counseling of GLP-1RA users undergoing implant-based procedures and for further research investigating the implications of perioperative use of these agents in plastic surgery.

  • Open Access

    Cosmetic Principles and Contemporary Techniques: Achieving Aesthetic Outcomes in DIEP Flap Breast Reconstruction

    by Christodoulos Kaoutzanis, Bilal F. Hamzeh, Markos Mardourian, David W. Mathes, Julian Winocour

    The deep inferior epigastric perforator (DIEP) flap holds its place as the gold standard approach for autologous tissue breast reconstruction given the strong durability, favorable donor site morbidity, and high patient satisfaction overall. With the reliability and safety of microsurgical reconstruction of the breasts being well-established over these last decades, the goals of DIEP flap reconstruction have expanded beyond flap survival toward optimization of aesthetic, patient-reported, and quality-of-life outcomes. Achieving ideal cosmesis requires thoughtful decision-making across the reconstructive continuum, including of radiation timing, mastectomy incision design, nipple–areolar complex management, reconstructive sequencing, flap shaping and inset, abdominal closure, neurotization, and the potential role of any revision or adjunctive procedures. Modern techniques including delayed-immediate reconstruction, nipple delay, free nipple grafting, fat grafting, and abdominal wall reinforcement have expanded the availability of personalized care in breast reconstruction. This narrative review integrates a targeted literature search with consensus-driven expert opinion informed by our senior authors’ extensive cumulative experience performing DIEP flap breast reconstruction. It discusses principles, technical strategies, and evolving evidence for optimizing aesthetic outcomes in DIEP flap breast reconstruction while preserving safety and minimizing morbidity.

  • Intraoperative Navigation in Orthognathic Surgery: Mitigating Iatrogenic Complications

    by Bilal F. Hamzeh, Anna D. Lee, Brooke French, Phuong Nguyen, Jason W. Yu, David W. Mathes, David Y. Khechoyan

    Orthognathic surgery requires precise manipulation of skeletal structures in close proximity to highly sensitive nerve, vascular, and airway anatomy. Rare iatrogenic injuries including hemorrhage and neurovascular compromise are reported and can have devastating sequelae including stroke, blindness, and death. Established technologies have primarily focused on positional accuracy rather than enhancing patient safety. This review investigates the adoption of intraoperative navigation in orthognathic surgery to reduce the risk of iatrogenic complications. Following PRISMA guidelines, a systematic search of PubMed, Embase, Web of Science, and Cochrane Library was conducted to identify original studies reporting on the application and outcomes of intraoperative navigation in orthognathic surgery. Data were extracted on indications, surgical procedures, navigation technologies, primary purpose for use, and outcomes. Thirty studies met inclusion criteria, and most were published after 2015 (63.3%). The majority (96.7%) used navigation to enhance accuracy of skeletal segment positioning; only 6.7% of studies reported use of intraoperative navigation to identify and avoid critical anatomic structures. BrainLab systems were most frequently used (40.0%), followed by Stryker (13.3%) and Aurora/Northern Digital Inc. (10.0%). Extensive evidence across multiple surgical specialties validates the efficacy of intraoperative navigation in reducing injury to critical structures and in limiting blood loss, operative time, and reoperation rates. Current literature supports intraoperative navigation as a highly accurate modality for orthognathic surgery but rarely addresses its potential to mitigate severe iatrogenic complications. Evidence from other surgical disciplines substantiates its role in enhancing safety, underscoring the need for high-level studies focused on complication prevention in orthognathic surgery.

  • Open Access

    Improving the Patient Experience in Breast Reconstruction: ERAS and Beyond

    by Evan J. Haas, Bilal F. Hamzeh, Zain Aryanpour, Jason W. Yu, David W. Mathes, Christodoulos Kaoutzanis

    Background and Objectives: Breast reconstruction after mastectomy has been shown to significantly improve psychosocial wellbeing and quality of life. Enhanced Recovery After Surgery (ERAS) protocols, especially those tailored to breast reconstruction, have revolutionized recovery by reducing complications, pain, opioid use, and hospital stay while improving patient satisfaction. The purpose of this narrative review was to present existing practices and supporting evidence within current ERAS protocols, as well as propose a modern ERAS framework centered around enhancing the patient experience following breast reconstruction. Methods: A focused literature search was conducted to identify studies investigating emerging approaches to patient care and surgical techniques adopted as part of a broader ERAS workflow Results: Some recent innovations include digital ERAS tracking, robot-assisted techniques, neurotization, and closed incision negative pressure therapy (ciNPT). These innovations show promise in reducing morbidity following reconstruction and may greatly improve sensory and functional outcomes. These advancements also reflect a shift toward more holistic, patient-centered care, extending beyond immediate clinical needs to address long-term wellbeing through psychosocial support and patient-reported outcome measures. Incorporating tools that validate patient perspectives helps guide interventions to optimize satisfaction and recovery. Conclusions: Future research should aim to standardize ERAS protocols by incorporating evidence-based practices, reinforcing breast reconstruction as a patient-centered, evidence-driven process that is focused on comprehensive recovery and improved quality of life.


  • Endurance exercise selectively elevates mBDNF across age groups in humans

    by Aaron Wang, Ryan Dang, Nicole Adara Case, Bilal F. Hamzeh

  • Open Access

    Colocalization of Cancer Associated Biomarkers on Single Extracellular Vesicles for Early Cancer Detection

    by Daniel P. Salem, Laura T. Bortolin, Dan Gusenleitner, Jonian Grosha, Ibukunoluwapo O. Zabroski, Kelly M. Biette, Sanchari Banerjee, Christopher R. Sedlak, Delaney M. Byrne, Bilal F. Hamzeh, et al.

    Detection of cancer early, when it is most treatable, remains a significant challenge due to the lack of diagnostic methods sufficiently sensitive to detect nascent tumors. Early-stage tumors are small relative to their tissue of origin, heterogeneous, and infrequently manifest in clinical symptoms. Detection of their presence is made more difficult by a lack of abundant tumor-specific indicators (i.e., protein biomarkers, circulating tumor DNA, etc.) that would enable detection using a non-invasive diagnostic assay. In addition, many benign conditions manifest in a similar manner, thus discriminating an early-stage cancerous lesion from a benign tumor can present additional challenges and result in unnecessary medical procedures. To overcome these obstacles, we have developed a liquid biopsy assay that interrogates circulating extracellular vesicles (EVs) to detect tumor-specific biomarkers colocalized on the surface of individual EVs. Extracellular vesicles from all cell types, including early-stage tumors, are known to be abundant in blood, are remarkably stable, and serve as a biopsy of their cell of origin. The detection of a colocalized combination of cancer associated biomarkers that provide tumor specificity on the surface of extracellular vesicles enables the discrimination of early- and late-stage cancer from non-malignant conditions.